CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR)

Historical Holders from Q3 2024 to Q3 2025

Symbol
CTOR on Nasdaq
CUSIP
17331Y109
Type / Class
Equity / Common stock, $0.0001 par value
Shares outstanding
78.4M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
8.36M
Holdings value
$17M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
16
Number of buys
13
Number of sells
-3
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Citius Pharmaceuticals, Inc. 79.1% $58.8M 66M Citius Pharmaceuticals, Inc. Sep 10, 2025
ARMISTICE CAPITAL, LLC 9.79% $15.5M 7.68M Armistice Capital, LLC Sep 30, 2025

Institutional Holders of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 8.36M $17M +$16.3M $2.03 16
2025 Q2 227K $990K +$574K $4.35 7
2025 Q1 105K $97.7K -$116K $0.93 6
2024 Q4 201K $230K +$181K $1.15 11
2024 Q3 41.2K $57K +$57K $1.39 7